| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
4 companies
Vivo Capital IX, LLC last filed a Form 4 in August 2023, as 10% Owner at TIL. The filings on record cover 4 companies.
Historically, Vivo Capital IX, LLC's trades have earned a middling insider score of 57/100 across 13 rated trades. Over a 12-month horizon, 46.2% of those trades were profitable, with an average 12-month return of +5.2%.
At the last filing, the largest reported position was 2,469,001 shares of TARS. The TARS filings lean toward selling, a net 526,034 shares.
Vivo Capital IX, LLC has 10 Form 4 filings on record from July 2020 to August 2023, across 4 companies: 10% Owner at IO Biotech (IOBT), 2021–2023; 10% Owner at Tarsus Pharmaceuticals (TARS), 2020–2022; 10% Owner at Instil Bio (TIL), 2021, and 1 more.
The 23 reported transactions were 10 open-market sales, 7 open-market purchases and 6 conversions.
Counted by filing, the open-market trades come to 5 purchases worth about $43.6M and 5 sales worth about $14.5M.
The largest open-market purchase was 975,000 shares of ALXO at an average $19.00 on July 21, 2020, about $18.5M.
The largest open-market sale was 512,956 shares of TARS at an average $13.39 on May 4, 2022, about $6.9M. Twelve months later TARS was up 17%.
Shares as reported in the last Form 4 for each company; the most recent is from August 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 | IOBT Io Biotech, Inc. | 10% Owner | Buy | 3,157,894 | $1.90 | $5,999,998.60 | New | -45.8% | -20.0% | |
| May 5, 2022 | TARS Tarsus Pharmaceuticals, Inc. | 10% Owner | Sell | 5,374 | $12.25 | $65,831.50 | -0.2% | +42.7% | +27.4% | |
| May 4, 2022 | TARS Tarsus Pharmaceuticals, Inc. | 10% Owner | Sell | 512,956 | $13.39 | $6,866,310.96 | -17.2% | +28.9% | +16.8% | |
| Nov 9, 2021 | IOBT Io Biotech, Inc. | 10% Owner | Buy | 650,000 | $14.00 | $9,100,000.00 | +27.5% | -36.9% | -81.2% | |
| Jun 25, 2021 | TARS Tarsus Pharmaceuticals, Inc. | 10% Owner | Sell | 55,684 | $29.79 | $1,658,842.40 | -1.8% | -22.5% | -48.0% | |
| Jun 22, 2021 | TARS Tarsus Pharmaceuticals, Inc. | 10% Owner | Sell | 201,620 | $29.05 | $5,856,114.00 | -6.2% | -24.7% | -51.5% | |
| Apr 14, 2021 | TARS Tarsus Pharmaceuticals, Inc. | 10% Owner | Sell | 400 | $30.37 | $12,148.00 | - | -7.6% | -38.8% | |
| Mar 23, 2021 | TIL Instil Bio, Inc. | 10% Owner | Buy | 300,000 | $20.00 | $6,000,000.00 | +2.5% | -28.9% | -58.7% | |
| Oct 20, 2020 | TARS Tarsus Pharmaceuticals, Inc. | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +8.3% | - | - | |
| Jul 21, 2020 | ALXO Alx Oncology Holdings Inc | 10% Owner | Buy | 975,000 | $19.00 | $18,525,000.00 | -123.5% | - | - |